首页> 外文期刊>Life sciences >MDOC (TM) and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE(-/-) mouse model of atherosclerosis
【24h】

MDOC (TM) and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE(-/-) mouse model of atherosclerosis

机译:MDOC(TM)和阿托伐他汀在动脉粥样硬化的apoE(-/-)小鼠模型的血管内皮中具有潜在的抗炎作用

获取原文
获取原文并翻译 | 示例
           

摘要

Members of the immunoglobulin superfamily of endothelial adhesion molecules, vascular cell adhesion molecule (VCAM-1) and intercellular cell adhesion molecule (ICAM-1), strongly participate in leukocyte adhesion to the endothelium and play all important role in all stages of atherogenesis. The aim of this study was to detect and quantity the changes of endothelial expression of VCAM-1, and ICAM-I in the vessel wall after the short-term administration of simvastatin, atorvastatin, and micro dispersed derivatives of oxidised cellulose (MDOC (TM)) in apolipoprotein-E-deficient (apoE(-/-)) mice atherosclerotic model. Hyperlipidemic apoE(-/-) mice (it =32) received normal chow diet or diet containing simvastatin or atorvastatin 10 mg/kg/day or MDOC (TM) 50 mg/kg/day. Total cholesterol, VLDL, LDL, HDL and TAG were measured and the endothelial expression of VCAM-1 and ICAM-1 was visualized and quantified by means of immunohistochemistry and stereology, respectively. Total cholesterol levels was insignificantly lowered only in MDOC (TM) treated mice but not in mice treated with statins. ICAM-1 endothelial expression was not affected by neither simvastatin nor MDOC (TM) treatment. However, significant diminution of VCAM-1 endothelial expression was observed in both atorvastatin and MDOC (TM) treated mice. These results provide new information of potential hypolipidemic substance MDOC (TM) and its potential anti-inflammatory effects. Furthermore, we have confirmed anti-inflammatory effects of atorvastatin independent of plasma cholesterol lowering. Thus, the results Of this Study show potential benefit of both M-DOC (TM) and atorvastatin treatment in apoE(-/-) Mouse model of atherosclerosis suggesting their possible combination might be of interest. (c) 2005 Elsevier Inc. All rights reserved.
机译:内皮粘附分子,血管细胞粘附分子(VCAM-1)和细胞间细胞粘附分子(ICAM-1)的免疫球蛋白超家族成员强烈参与白细胞与内皮的粘附,并在动脉粥样硬化形成的所有阶段均发挥重要作用。这项研究的目的是检测和定量短期施用辛伐他汀,阿托伐他汀和微分散的氧化纤维素衍生物(MDOC(TM)后血管壁中VCAM-1和ICAM-1的内皮表达))在缺乏载脂蛋白E的(apoE(-/-))小鼠动脉粥样硬化模型中。高脂血症apoE(-/-)小鼠(= 32)接受正常食物或含有辛伐他汀或阿托伐他汀10 mg / kg /天或MDOC(TM)50 mg / kg /天的饮食。测量总胆固醇,VLDL,LDL,HDL和TAG,并分别通过免疫组织化学和立体学对VCAM-1和ICAM-1的内皮表达进行可视化和定量。总胆固醇水平仅在经MDOC(TM)处理的小鼠中显着降低,而在用他汀类药物治疗的小鼠中未降低。辛伐他汀或MDOC(TM)处理均不影响ICAM-1内皮表达。但是,在阿托伐他汀和MDOC(TM)处理的小鼠中均观察到VCAM-1内皮表达显着减少。这些结果提供了潜在的降血脂物质MDOC(TM)及其潜在的抗炎作用的新信息。此外,我们已经证实了阿托伐他汀的抗炎作用与血浆胆固醇的降低无关。因此,这项研究的结果显示M-DOC(TM)和阿托伐他汀治疗在apoE(-/-)动脉粥样硬化小鼠模型中的潜在益处,表明它们的可能组合可能是令人感兴趣的。 (c)2005 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号